Related Experiment Video

Updated: Jul 29, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer

Mira Al Jaberi, Wolfgang Clough, Samir Dalia

    Oncotarget
    |May 26, 2023
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    MET mutationnon small cell lung cancerprecision medicinetargeted therapy

    More Related Videos

    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
    09:38

    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

    Published on: August 11, 2017

    8.9K
    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    24.4K

    Related Experiment Videos

    Last Updated: Jul 29, 2025

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.2K
    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
    09:38

    Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

    Published on: August 11, 2017

    8.9K
    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    24.4K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    7.7K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    7.7K

    Articles linked to this work by shared authors, journal, and citation graph.

    Concurrent Superior Mesenteric and Splenic Vein Thrombosis in a Prothrombin G20210A Carrier: Radiologic Evolution and Resolution on Apixaban.

    Cureus·2026

    Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution.

    Cureus·2026

    Infectious disease burden and surveillance challenges in Jordan and Palestine: a systematic review and meta-analysis.

    Frontiers in digital health·2026

    Non-gastric mucosa-associated lymphoid tissue lymphomas: a narrative review of pathogenesis, diagnosis, and treatment strategies.

    Annals of translational medicine·2026

    T-cell prolymphocytic leukemia, a case report and review of the literature.

    Oncology research·2025

    Loncastuximab Tesirine in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

    International journal of molecular sciences·2024

    Are both COVID-19 and COVID-19 vaccines associated with cancer?

    Oncotarget·2026

    Re-expression of MHC-I to treat CNS cancers.

    Oncotarget·2026

    Are Urooncologists Onboard?

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    The State of the Art of Theranostics and Its Future.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    [Alzheimer's disease: scientific advances, diagnostic challenges and therapeutic perspectives].

    Soins; la revue de reference infirmiere·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us